Biomedical Engineering MPhil in Keele United Kingdom | Keele University

A cross-disciplinary research team affiliated with the University Hospital of North Midlands (UHNM) and RJAH Orthopaedic Hospital in Oswestry specializes in developing advanced technologies for cell and tissue engineering, along with implementing cellular therapies for regenerative medicine in clinical settings.OverviewThis collaborative group connected to UHNM and RJAH Orthopaedic Hospital concentrates on pioneering technologies in cellular engineering and bringing regenerative cell treatments into healthcare practice. Their specialized knowledge encompasses active clinical cellular treatments, innovation in environmental chamber and bioreactor technology, magnetic nanoparticle delivery systems, and directing the specialization of tissue-specific and skeletal stem cells. Since 2009, the team has co-managed an EPSRC Doctoral Training Centre for Regenerative Medicine in partnership with Nottingham and Loughborough universities.The Institute launched the UK's first MRC multi-center clinical study (ACTIVE) exploring cellular treatments for connective tissue disorders. Both hospital locations feature GMP-certified laboratories for cultivating and administering human cell therapies. Recently, the group became a partner in the inaugural EPSRC Innovative Manufacturing Centre for Regenerative Medicine, fostering industry collaborations to commercialize cellular therapies for tangible patient outcomes. They also participate in the EXPERTISSUES EU FP6 Network of Excellence. The BT research cluster maintains connections with other disciplines including Respiratory Medicine, Pharmacy, Clinical Science, Imaging, and Neurology. Additionally, the team established an international research network through the EU FP7 IRSES HYANJI initiative, linking with China's Tsinghua and Chengdu Universities in pharmaceutical and biotechnology studies.The Bioengineering and Therapeutics Group represents a multidisciplinary collaboration between the University Hospital of North Staffordshire and RJAH Orthopaedic Hospital, focusing on technological advancements in cellular engineering and clinical implementation of regenerative therapies.Their expertise spans operational clinical cell treatments, innovations in bioreactor systems and environmental control technologies, magnetic nanoparticle delivery methods, and guiding stem cell differentiation processes. Since 2009, they've jointly operated an EPSRC Doctoral Training Centre in Regenerative Medicine with Nottingham and Loughborough universities.The Institute pioneered the UK's first MRC multi-center investigation (ACTIVE) into connective tissue cellular therapies, supported by on-site GMP cell culture facilities. As partners in the EPSRC Innovative Manufacturing Centre for Regenerative Medicine, they work to strengthen industry partnerships for therapeutic commercialization. They contribute to the EXPERTISSUES EU FP6 Network and maintain research connections across multiple medical disciplines. Through the HYANJI EU IRSES program, they've built academic partnerships with Chinese institutions including Tsinghua and Chengdu Universities' pharmaceutical and biotechnology departments.Current UK visa policies generally require international fee-status students to enroll full-time unless pursuing distance learning programs.